MedPath

Soy Isoflavone on hot flushes, endometrial thickness and breast clinical and sonographic

Phase 3
Conditions
Hot flash.
Registration Number
IRCT20100706004329N5
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
204
Inclusion Criteria

over 40 years of age
body mass index in range of 20-35Kg/m2
With hot flushes

Exclusion Criteria

Women with previous history of cancer,diabetes mellitus or renal, hepatic, and heart failure or abnormal uterine bleeding, mioma, ovarian cyst, Poly Cystic Ovarian syndrome(PCOS), endometriosis
hormone therapy during the last three months,
Patients with disability or known history of drug or alcohol consumption
Cigarette smoking and caffeine consumption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hot flashing were categorized in mild, moderate and severe. Timepoint: before and 6 and 12 months after intervention. Method of measurement: questionnaire.
Secondary Outcome Measures
NameTimeMethod
Endometrial thickness. Timepoint: Before and 6, 12 months after intervention. Method of measurement: Endometrial thickness was evaluated using ulthrasonography.;Breast changes. Timepoint: Before and 6, 12 months after intervention. Method of measurement: Breast sonography.
© Copyright 2025. All Rights Reserved by MedPath